On 25 April 2017, the Financial Times will host the third annual FT Asia Healthcare & Life Sciences Summit at The Westin Singapore. The theme this year is Shaping the future of healthcare, with the Summit bringing together government leaders, industry experts and senior business executives from across the region to discuss how initiatives taken today can improve Asia’s healthcare landscape tomorrow. 

This prestigious event will address some of Asia’s formidable healthcare challenges, including the surge in age-related healthcare demands and non-communicable diseases – especially diabetes, which are putting additional strain on healthcare systems already struggling to cope. The summit will explore how governments can open the door to private investment while balancing a responsibility to provide basic access to healthcare, and how global and local healthcare companies in turn can benefit from, and improve, the healthcare landscape.

Thought leaders will provide insights into how healthcare can be made sustainable, and respond to critical problems that the industry faces. Technological disruptions and innovations in healthcare will be addressed by Bruce Liang, CEO, Integrated Health Information Systems and CIO, Ministry of Health, Singapore, along with other digital health experts. Herve Gisserot, Head of Pharmaceuticals Asia-Pacific, GlaxoSmithKline, will elaborate on the business of healthcare, while Roy Quek, Executive Chairman, Thomson Medical Group, will present his viewpoint on medical tourism. Zee Yoong Kang, CEO, Health Promotion Board, Singapore, will talk about patient-centred healthcare. Other speakers include Patrick Tan Boon Ooi, Deputy Executive Director, Biomedical Research Council, Agency for Science, Technology and Research; Isabel Torres, Global Lead for Access to Medicines, Takeda Pharmaceuticals; and Allen Lai, Regional Managing Director, ACT Genomics Singapore.

This summit is presented by the Financial Times with the support of Deloitte.